Endocrinology · 1997 · 118 citations · 0 references
Life SciencesCell BiologyEndocrinologyApoptosisCell PhysiologyDevelopmental Cell BiologyApoptosis In DevelopmentApoptosis In Tissue HomeostasisApoptosis RegulationCell DeathDevelopmental EndocrinologyPancreatic EndocrinologyApoptotic Cell IdentificationBeta Cell ApoptosisBeta Cell BiologyBeta Cell ProliferationCell Mass AccumulationIslet Cell MassNeonatal Growth Assessment
In rodents, shortly after birth a lack of increase in pancreatic weight and in islet mass have been reported during a time of overall body weight increase. To understand this regulation of the neonatal growth of the β cell mass, we studied Sprague Dawley rats at 2, 9, 13, 17, 20, 24, and 31 days of age for β cell replication, β cell mass, and cell size and for the presence of β cell apoptosis. β cell mass was stable from 2–20 days (range: 0.91 ± 0.2 to 1.33 ± 0.23 mg) and increased thereafter. β cell replication progressively decreased. Condensed apoptotic nuclei were identified and counted on paraffin sections using the fluorescent dye propidium iodide. Apoptoticβ cell nuclei were found at a basal rate (1.54 ± 0.22%) at 2, 9, and again after 20 days of age. However, at 13 and 17 days, the incidence of apoptosis was significantly increased (3.64 ± 0.45%). The decreased replication and the increased incidence of apoptosis in the β cells strongly suggest a wave of neogenesis of β cells to maintain the constant β cell mass. These data show that the endocrine pancreas undergoes significant modification during neonatal life and that apoptosis is an important mechanism in this remodeling of the β cell mass. Whether a selective deletion of some population ofβ cells occurs is unclear, but a dysregulation of this remodeling process could have important effects on the pancreatic β cell mass.